Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Gordon J. S. Rustin

Department of Medical Oncology

Charing Cross Hospital

London

United Kingdom

[email]@mtvern.co.uk

Name/email consistency: high

[Claim this account]

Affiliations

Department of Medical Oncology, Charing Cross Hospital, London, United Kingdom. 1996 - 2004
Cancer Treatment Centre, and Gray Laboratory, Mount Vernon Hospital, Northwood, United Kingdom. 2000
Mount Vernon Hospital, Northwood, UK. 1999

References

Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer. Rustin, G.J., Bast, R.C., Kelloff, G.J., Barrett, J.C., Carter, S.K., Nisen, P.D., Sigman, C.C., Parkinson, D.R., Ruddon, R.W. Clin. Cancer Res. (2004) [Pubmed]
5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent: phase I clinical and pharmacokinetic study. Rustin, G.J., Bradley, C., Galbraith, S., Stratford, M., Loadman, P., Waller, S., Bellenger, K., Gumbrell, L., Folkes, L., Halbert, G. Br. J. Cancer (2003) [Pubmed]
Use of CA-125 to assess response to new agents in ovarian cancer trials. Rustin, G.J. J. Clin. Oncol. (2003) [Pubmed]
Phase I clinical trial of weekly combretastatin A4 phosphate: clinical and pharmacokinetic results. Rustin, G.J., Galbraith, S.M., Anderson, H., Stratford, M., Folkes, L.K., Sena, L., Gumbrell, L., Price, P.M. J. Clin. Oncol. (2003) [Pubmed]
Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels. Rustin, G.J., Marples, M., Nelstrop, A.E., Mahmoudi, M., Meyer, T. J. Clin. Oncol. (2001) [Pubmed]
Selection of active drugs for ovarian cancer based on CA-125 and standard response rates in phase II trials. Rustin, G.J., Nelstrop, A.E., Bentzen, S.M., Bond, S.J., McClean, P. J. Clin. Oncol. (2000) [Pubmed]
Use of tumour markers in monitoring the course of ovarian cancer. Rustin, G.J., Nelstrop, A.E., Bentzen, S.M., Piccart, M.J., Bertelsen, K. Ann. Oncol. (1999) [Pubmed]
Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. Rustin, G.J., Newlands, E.S., Lutz, J.M., Holden, L., Bagshawe, K.D., Hiscox, J.G., Foskett, M., Fuller, S., Short, D. J. Clin. Oncol. (1996) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.